Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if TXMD is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
7 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
45 filers reported a long position in TXMD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Rubric Capital Management LP | $2.6M | 1.2M | Unchanged |
| Clearline Capital LP | $1.4M | 635.2K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $781.7K | 353.7K | Unchanged |
| Tejara Capital Ltd | $761.3K | 344.5K | -0.4% |
| ADAR1 Capital Management, LLC | $756.8K | 342.4K | +63.7% |
| RENAISSANCE TECHNOLOGIES LLC | $324K | 146.6K | +0.3% |
| MORGAN STANLEY | $285.6K | 129.2K | Unchanged |
| BlackRock, Inc. | $254.5K | 115.1K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $234K | 105.8K | -3.6% |
| CITADEL ADVISORS LLC | $190.3K | 86.1K | +26% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.